• Tariff headlines, ‘Magazine 7’ earnings, U.S. jobs report, and PCE inflation information will likely be in focus this week.
• Meta is predicted to report better-than-feared earnings on account of an enhancing digital...
(Reuters) -U.S. drugmaker Pfizer (NYSE:) stated on Wednesday it's withdrawing its sickle cell illness remedy Oxbryta from all markets the place it's authorised, citing dangers of a painful complication and...
Regardless of a long-term downtrend since December 2021, Pfizer's inventory should still be undervalued
The corporate is now aiming to ascertain a steady, growth-oriented mannequin following a yr of stagnation
Pfizer's general monetary well being...
Budrul Chukrut | Lightrocket | Getty PhotosTake a look at the businesses making headlines in noon buying and selling.Lucid Group — Lucid shares jumped 9% after the electric-vehicle maker mentioned it'll present powertrain...
